|
% ED use every two weeks +
|
46 (41–51)
|
39 (33–44)
|
30 (19–44)
|
26 (21–32)
|
0.75 (0.55–1.00),
p
= .054
|
0.51 (0.27–0.96),
p
= .037
|
0.42 (0.30–0.59),
p
< .001
|
|
% Monthly or more frequent intake in excess of guidelines
|
19 (15–23)
|
11 (8–15)
|
10 (4–21)
|
7 (5–11)
|
0.54 (0.35–0.83),
p
= .005
|
0.48 (0.18–1.24), p = .130
|
0.34 (0.20–0.57),
p
< .001
|
|
Typical ED intake (M, SD)
|
1.6 (1.1)
|
1.4 (0.7)
|
1.7 (1.7)
|
1.4 (1.0)
|
0.74 (0.62–0.89),
p
= .002
|
1.04 (0.83–1.31), p = .724
|
0.82 (0.69–0.98),
p
= .027
|
|
% Typical intake exceeds ED guidelines
|
8 (6–10)
|
11 (8–15)
|
6 (4–9)
|
9 (4–20)
|
0.49 (0.27–0.87),
p
= .016
|
0.75 (0.26–2.21), p = .605
|
0.54 (0.30–0.99),
p
= .046
|
|
Maximum ED intake (M, SD)
|
2.9 (2.3)
|
2.3 (1.7)
|
2.9 (3.7)
|
2.1 (2.0)
|
0.87 (0.80–0.95),
p
= .001
|
1.01 (0.90–1.12), p = .921
|
0.81 (0.74–0.90),
p
< .001
|
|
% Maximum intake exceeds ED guidelines
|
43 (38–48)
|
27 (22–32)
|
36 (23–50)
|
24 (20–30)
|
0.50 (0.36–0.69),
p
< .001
|
0.74 (0.39–1.41), p = .364
|
0.44 (0.31–0.62),
p
< .001
|
